It's a consistent problem.

A new ad campaign kicks off this week.

That makes government efforts help get medications to low-income patients even harder.

Its prospects for success don’t look great at this point.

Block grants are on the table.

Medicare and Medicaid took a beating though.

It's another sign of the tension with moderates.

It's unclear what the ONDCP has actually done.

And not everyone is happy.

Sen. Mike Braun wants to ban rebates in private sector.

'I look for where I can get a result,' said HELP Chair Lamar Alexander.

But they're seeking a balance.

Sen. Bill Cassidy is one of them.

Only 7 of 42 House Democrats who flipped GOP-held districts in 2018 are co-sponsoring the measure.

Five takeaways from the hearing on the Hill.

That's the assessment of one expert as drugmakers head to the Hill this morning.

Think Lyrica, Crestor, Keytruda.

Load More